Actualizado 29/05/2008 20:47
- Comunicado -

New Published Data Support Safety and Efficacy of RESOLOR(R) for Treatment of Chronic Constipation (y 2)

-- M0004, another gastrokinetic compound for motility complaints related to non erosive or refractory gastro-oesophageal reflux disease (GORD) ready to move into clinical development.

References

1. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation. NEJM 2008 In Press

2. A Drossman (2006) Rome III: The new criteria. Chinese Journal of Digestive Diseases 7 (4) , 181-185.

3. IMS Health.

4. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750-9.

Vicki Martin, Tel: +44(0)20-8439-9407, vmartin@axon-com.com; Sarah Griffin, Tel: +44(0)20-8439-9582, sgriffin@axon-com.com

Contenido patrocinado